PHF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.284600E-01
Normal-vs-Stage2
4.613400E-01
Normal-vs-Stage3
2.868600E-01
Normal-vs-Stage4
6.900600E-01
Stage1-vs-Stage2
6.446600E-01
Stage1-vs-Stage3
2.684300E-02
Stage1-vs-Stage4
4.948000E-01
Stage2-vs-Stage3
1.330570E-01
Stage2-vs-Stage4
2.030800E-01
Stage3-vs-Stage4
1.493970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.532600E-01
Normal-vs-AfricanAmerican
4.670800E-01
Normal-vs-Asian
3.724800E-01
Caucasian-vs-AfricanAmerican
9.761800E-01
Caucasian-vs-Asian
2.901200E-01
AfricanAmerican-vs-Asian
4.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.505800E-01
Normal-vs-Female
4.530200E-01
Male-vs-Female
9.595800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.563000E-01
Normal-vs-Age(41-60Yrs)
5.637000E-01
Normal-vs-Age(61-80Yrs)
4.072000E-01
Normal-vs-Age(81-100Yrs)
4.219200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.879000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.477400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.915000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.777800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.598640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.180800E-01
Normal-vs-Daily Drinker
3.868000E-01
Normal-vs-Weekly Drinker
3.644600E-01
Normal-vs-Occasional Drinker
5.862000E-01
Normal-vs-Social Drinker
4.700400E-01
Non Drinker-vs-Daily Drinker
6.462000E-01
Non Drinker-vs-Weekly Drinker
4.464000E-01
Non Drinker-vs-Occasional Drinker
8.841900E-02
Non Drinker-vs-Social Drinker
5.518000E-01
Daily Drinker-vs-Weekly Drinker
7.973200E-01
Daily Drinker-vs-Occasional Drinker
7.466100E-02
Daily Drinker-vs-Social Drinker
3.865000E-01
Weekly Drinker-vs-Occasional Drinker
4.386300E-02
Weekly Drinker-vs-Social Drinker
2.283800E-01
Occasional Drinker-vs-Social Drinker
3.381200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.950750E-01
Normal-vs-Grade 2
4.359700E-02
Normal-vs-Grade 3
4.033600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.969700E-02
Grade 1-vs-Grade 3
2.511800E-02
Grade 1-vs-Grade 4
1.950750E-01
Grade 2-vs-Grade 3
2.645200E-01
Grade 2-vs-Grade 4
4.359700E-02
Grade 3-vs-Grade 4
4.033600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.968800E-01
Normal-vs-NonDiabetic
4.320000E-01
Diabetic-vs-NonDiabetic
4.381200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.123400E-01
Normal-vs-NoPancreatitis
4.325200E-01
Pancreatitis-vs-NoPancreatitis
7.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.456400E-01
Normal-vs-N1
4.595600E-01
N0-vs-N1
7.601000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.408800E-01
Normal-vs-TP53-NonMutant
4.870200E-01
TP53-Mutant-vs-TP53-NonMutant
3.554000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
